Medical Innovations Patent Mitra: Innovators-to-Industry (I2I) Connect
Why in News?
Medical Innovations Patent Mitra: Innovators-to-Industry (I2I) Connect is in the news because Indian Council of Medical Research (ICMR) organized it in New Delhi as India’s largest biomedical innovation and technology transfer facilitation event, aimed at speeding up commercialization of indigenous healthcare technologies.
Other Key Points
- Massive Technology Transfer: ICMR officially licensed out 41 groundbreaking public health innovations to the private sector for commercial manufacturing and widespread deployment.
- National Conclave Launch: The event established India's first structured, national-level platform explicitly dedicated to showcasing biomedical tech and fast-tracking intellectual property licensing.
- High-Value Vaccine Transfers: The event featured the transfer of critical, indigenously developed medical breakthroughs, including a Recombinant Malaria Vaccine, a Salmonella Vaccine, and a Shigella Vaccine.
- Strategic Roadmap Releases: The Union Ministry officially unveiled two pivotal ecosystem documents: the 'Indian Biomedical Patent Landscape Report' and the comprehensive ‘Technology Compendium’.
- High-Level Governance Backing: The initiative was inaugurated by Union Minister of State Prataprao Ganpatrao Jadhav alongside Prof. Gobardhan Das, an official member of NITI Aayog.
Institutional Framework & Guidance
- Nodal Agency: The platform is entirely run by the Innovation and Translational Research (ITR) Unit of ICMR, under the Ministry of Health and Family Welfare.
- Inter-Ministerial Alliance: Developed under the direct guidance of NITI Aayog, in active partnership with the Department of Pharmaceuticals (DoP) and the Department for Promotion of Industry and Internal Trade (DPIIT).
- Ultimate Goal: Designed to securely shift India’s pharmaceutical and MedTech sector away from a cost-driven generic model into an innovation-led global powerhouse ahead of the Viksit Bharat 2047 vision.
Key Features & Handholding Services
- Zero-Cost Support: Operating as a 100% free digital service providing full lifecycle assistance for researchers who cannot afford heavy legal fees.
- End-to-End Intellectual Property Care: Offers expert assistance with initial patentability assessments, patent drafting, domestic filing, prosecution, and maintenance.
- Paperless Facilitation: Utilises an entirely automated online portal to process Expressions of Interest (EoI) and seamlessly link research institutions to commercial entities.
- Target Beneficiaries: Provides complete operational backing to ICMR Intramural Institutes, Extramural Grantees, independent Medical Colleges, and DPIIT-registered startups.
- Special Infrastructure Access: Connects qualified commercial partners directly with world-class, government-managed ICMR biomaterial repositories for advanced trial validations.
Download Pdf
